BR112022016249A2 - Métodos de preparação de derivados quirais de benzodiazepinona - Google Patents
Métodos de preparação de derivados quirais de benzodiazepinonaInfo
- Publication number
- BR112022016249A2 BR112022016249A2 BR112022016249A BR112022016249A BR112022016249A2 BR 112022016249 A2 BR112022016249 A2 BR 112022016249A2 BR 112022016249 A BR112022016249 A BR 112022016249A BR 112022016249 A BR112022016249 A BR 112022016249A BR 112022016249 A2 BR112022016249 A2 BR 112022016249A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- compound
- benzodiazepinone
- preparation
- integer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062977316P | 2020-02-16 | 2020-02-16 | |
| PCT/US2021/018137 WO2021163676A1 (en) | 2020-02-16 | 2021-02-16 | Methods of preparing chiral benzodiazepinone derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022016249A2 true BR112022016249A2 (pt) | 2022-10-11 |
Family
ID=77291712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022016249A BR112022016249A2 (pt) | 2020-02-16 | 2021-02-16 | Métodos de preparação de derivados quirais de benzodiazepinona |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12503449B2 (https=) |
| EP (1) | EP4107148A4 (https=) |
| JP (1) | JP2023513731A (https=) |
| KR (1) | KR20220143094A (https=) |
| CN (1) | CN115103836A (https=) |
| AU (1) | AU2021218456A1 (https=) |
| BR (1) | BR112022016249A2 (https=) |
| CA (1) | CA3171651A1 (https=) |
| IL (1) | IL295572A (https=) |
| MX (1) | MX2022010079A (https=) |
| WO (1) | WO2021163676A1 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0253571B1 (en) * | 1986-07-14 | 1989-08-23 | Merck & Co. Inc. | Process for resolution and race mization of amines with acidic alpha-hydrogens |
| NL9000386A (nl) * | 1990-02-16 | 1991-09-16 | Stamicarbon | Werkwijze voor de bereiding van optisch aktief aminozuuramide. |
| JPH0751555B2 (ja) | 1992-04-15 | 1995-06-05 | キヤノン株式会社 | ジイモニウム塩化合物 |
| BRPI0520554A2 (pt) * | 2005-09-19 | 2009-06-13 | Arrow Therapeutics Ltd | uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica |
| WO2010073253A1 (en) | 2008-12-22 | 2010-07-01 | Natco Pharma Limited | Method for preparing an optically active frovatriptan |
| WO2013148554A1 (en) * | 2012-03-30 | 2013-10-03 | Merck Sharp & Dohme Corp. | Process for preparing fluoroleucine alkyl esters |
| CN105308030A (zh) * | 2012-09-21 | 2016-02-03 | 百时美施贵宝公司 | 烷基、氟烷基-1,4-苯并二氮杂*酮化合物 |
| EP2897942B1 (en) | 2012-09-21 | 2016-08-31 | Bristol-Myers Squibb Company | Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch inhibitors |
| WO2014047392A1 (en) | 2012-09-21 | 2014-03-27 | Bristol-Myers Squibb Company | Fluoroalkyl-1,4-benzodiazepinone compounds |
| TWI614238B (zh) * | 2012-09-21 | 2018-02-11 | 必治妥美雅史谷比公司 | 雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥 |
| JP6687596B2 (ja) | 2015-02-17 | 2020-04-22 | アモーレパシフィック コーポレーションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ | Ｎ−［４−（１−アミノエチル）−フェニル］−スルホンアミド誘導体のキラル分割方法 |
| CN105439939B (zh) | 2015-11-12 | 2018-12-04 | 四川恒康科技发展有限公司 | 一种(S)-N-Boc-3-羟基哌啶的合成方法 |
-
2021
- 2021-02-16 CN CN202180014113.5A patent/CN115103836A/zh active Pending
- 2021-02-16 JP JP2022548818A patent/JP2023513731A/ja active Pending
- 2021-02-16 MX MX2022010079A patent/MX2022010079A/es unknown
- 2021-02-16 CA CA3171651A patent/CA3171651A1/en active Pending
- 2021-02-16 WO PCT/US2021/018137 patent/WO2021163676A1/en not_active Ceased
- 2021-02-16 IL IL295572A patent/IL295572A/en unknown
- 2021-02-16 BR BR112022016249A patent/BR112022016249A2/pt unknown
- 2021-02-16 KR KR1020227032186A patent/KR20220143094A/ko active Pending
- 2021-02-16 EP EP21753186.2A patent/EP4107148A4/en active Pending
- 2021-02-16 US US17/799,680 patent/US12503449B2/en active Active
- 2021-02-16 AU AU2021218456A patent/AU2021218456A1/en active Pending
-
2025
- 2025-07-24 US US19/279,615 patent/US20250346565A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN115103836A (zh) | 2022-09-23 |
| MX2022010079A (es) | 2022-09-02 |
| US20250346565A1 (en) | 2025-11-13 |
| CA3171651A1 (en) | 2021-08-19 |
| EP4107148A1 (en) | 2022-12-28 |
| WO2021163676A1 (en) | 2021-08-19 |
| EP4107148A4 (en) | 2024-05-15 |
| IL295572A (en) | 2022-10-01 |
| US20230108536A1 (en) | 2023-04-06 |
| US12503449B2 (en) | 2025-12-23 |
| AU2021218456A1 (en) | 2022-09-22 |
| KR20220143094A (ko) | 2022-10-24 |
| JP2023513731A (ja) | 2023-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0607062A2 (pt) | composto de aminopiridina com atividade inibidora de syk, composição farmacêutica e agente terapêutico compreendendo os mesmos | |
| BRPI0509471A (pt) | lipìdios, complexos de lipìdio e uso dos mesmos | |
| RU2224746C2 (ru) | Фитопатогенный фунгицид, производное 2-пиридилметиламина, фунгицидная композиция, способ борьбы с фитопатогенными грибами | |
| BR9915895A (pt) | Composto, uso do mesmo, processo para prepará-lo, método para o tratamento de um mamìfero, incluindo o homem, de condições resultantes de nìveis de circulação elevados de apob-100, e, composição farmacêutica | |
| Azar et al. | Phototoxicity of strained Ru (ii) complexes: is it the metal complex or the dissociating ligand? | |
| Akl et al. | Comparative photo-release of nitric oxide from isomers of substituted terpyridinenitrosylruthenium (II) complexes: experimental and computational investigations | |
| FR2403337A1 (fr) | N-(heterocyclique aminocarbonyl)aryl sulfonamides herbicides, compositions les contenant et procedes les utilisant | |
| DK365184D0 (da) | 1,8-naphthyridinderivater eller estre eller salte deraf, deres fremstilling og anvendelse som farmaceutika | |
| SE8306469L (sv) | Elektrolytiskt forfarande och anordning | |
| BR112022016249A2 (pt) | Métodos de preparação de derivados quirais de benzodiazepinona | |
| RU2004129593A (ru) | Офтальмическая композиция, содержащая аскомицин | |
| RU95113442A (ru) | Азоксицианобензольное соединение, способы его получения, фунгицидная композиция и способы борьбы с грибками | |
| Chibisov et al. | Photosensitized processes in dicarbocyanine dyes induced by energy transfer: delayed fluorescence, trans→ cis isomerization and electron transfer | |
| Sabater et al. | Enhancement of anion recognition exhibited by a zinc-imidazole-based ion-pair receptor composed of C–H hydrogen-and halogen-bond donor groups | |
| Ilic et al. | Investigation into dual emission of a cyclometalated iridium complex: The role of ion-pairing | |
| AR054831A1 (es) | Derivados de heptaazafenaleno, procedimientos para su obtencion, asi como utilizacion de los mismos como agentes protectores contra la radiacion uv | |
| GB1362859A (en) | Heterocyclic quaternary salts and their use in photographic silver halide emulsions | |
| FR2361366A1 (fr) | Derives heterocycliques de la guanidine | |
| US2747996A (en) | Photographic element protected against action of ultraviolet radiation | |
| Takagi et al. | Visible-light-sensitized cis-trans isomerization of N-methyl-4-(. beta.-styryl) pyridinium ions | |
| Uzgoren-Baran et al. | A naproxen derived schiff-base for highly selective sensing of fluoride | |
| Haidar et al. | 1, 2, 3-triazole-totarol conjugates as potent PIP5K1α lipid kinase inhibitors | |
| SE7712733L (sv) | Substituerade o-fenylendiaminderivat, sett for framstellning samt anvendning derav som lekemedel | |
| KR890701139A (ko) | Tc-99m 방사성의약품의 제조 | |
| ES336066A1 (es) | Procedimiento para la preparacion de derivados de ciclopropano diarilico. |